Large-scale testing (Phase 3)Study completedNCT00841763
What this trial is testing
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
Who this might be right for
Pandemic Influenza Disease
Novartis 3,647